Munich-based Brainlab Pursues Initial Public Offering
Headline: hey, let's talk about Brainlab, a tech-savvy medical firm eyeing big profits through an IPO
Brainlab set to raise serious cash with Frankfurt Stock Exchange debut The Munich-based medical giant, Brainlab, is gearing up to list on the Frankfurt Stock Exchange this summer. The company aims to rake in up to 200 million euros through the issuance of new shares, targeting opportunities in AI, AR, and cloud technologies.
Seizing Opportunities With over 2000 employees offering software and hardware for operations and tumor radiation therapies, a whopping 4000 clinics rely on Brainlab's tech. Founder Stefan Vilsmeier believes the timing is right for an IPO, citing the potential presented by advanced tech like AI, AR, and cloud. Retirement of roughly 30% of healthcare sector workers in the next decade further solidifies the opportunities.
Meet the Main Players Brainlab CEO Rainer Birkenbach confirms that the primary focus is on organic growth, with investments in technologies taking a backseat. As for the IPO's planning, Berenberg, Deutsche Bank, Commerzbank, Jefferies, and Unicredit are on board as organizers, while Evercore provides advice. Insider reports point to a valuation of two to three billion euros.
Vilsmeier currently holds a majority of shares, with external investors like EMH Partners joining the mix. To maintain sufficient float, existing shareholders are strategizing to sell some of their shares. Nonetheless, Vilsmeier expressed confidence in his long-term commitment to Brainlab.
Why Brainlab Matters After debuting 35 years ago, Brainlab has grown steadily, achieving 239 million euros in turnover in the first half of the year, with a 22.4% operating profit margin. The company had previously tried to go public in 2001, but called it off at the last minute due to market instability. Brainlab is the second company poised to announce an IPO this summer, following in the footsteps of Berlin-based auto parts retailer Autodoc.
Sources: ntv.de, raf/rts
- IPOs
- Germany
- Healthcare Technology
- Investment Banking
Bonus fact: About 30% of workers in the healthcare sector are estimated to retire within the next ten years, creating a significant potential for growth in the industry.
- Brainlab, in its pursuit of an IPO, has established partnerships with several investment banks, including Berenberg, Deutsche Bank, Commerzbank, Jefferies, and Unicredit, to raise funds for investments in technological advancements such as AI, AR, and cloud, as well as vocational training for its employees to improve their skills in accordance with the community policy and employment policy.
- In addition to generating substantial profits through the IPO on the Frankfurt Stock Exchange, Brainlab's focus on organic growth and strategic sale of shares by existing shareholders is expected to provide a stable financial foundation, enabling the company to allocate funds towards various initiatives, such as finance for vocational training programs and adherence to its employment policy, all while preparing for the impending retirement of nearly one-third of the healthcare sector workforce over the next decade.
